SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039816
Filing Date
2023-06-26
Accepted
2023-06-26 19:39:13
Documents
1
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4053
  Complete submission text file 0001209191-23-039816.txt   5563
Mailing Address C/O PELOTON THERAPEUTICS, INC. 2330 INWOOD ROAD, SUITE 226 DALLAS TX 75235
Business Address
Josey John A. (Reporting) CIK: 0001776351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 231043711

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations